New products
Precision Diabetes and DirectSens to introduce MetMark test in US
Precision Diabetes and DirectSens have partnered to commercialize the MetMark clinical test in the US. The test measures AHB and 2-HB biomarkers associated with metabolic dysfunction and type 2 diabetes risk. The collaboration marks the US market entry for this diagnostic offering.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network